Haemonetics Corp. (HAE)
59.53
+2.68
(+4.71%)
USD |
NYSE |
May 20, 16:00
59.80
+0.27
(+0.45%)
Pre-Market: 20:00
Haemonetics EPS Diluted (Quarterly) : -0.4359 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Envista Holdings Corp. | 0.2326 |
| Edwards Lifesciences Corp. | 0.6556 |
| Integra LifeSciences Holdings Corp. | -0.06 |
| QuidelOrtho Corp. | -1.346 |
| Dentsply Sirona, Inc. | -0.05 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.15M |
| Revenue (Quarterly) | 346.35M |
| Total Expenses (Quarterly) | 366.50M |
| Enterprise Value | 3.563B |
| Gross Profit Margin (Quarterly) | 57.23% |
| Profit Margin (Quarterly) | -5.82% |
| Earnings Yield | 3.41% |
| Operating Earnings Yield | 8.64% |
| Normalized Earnings Yield | 5.704 |